The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aspen Aerogels | Common | 04523Y105 | 19,226 | 3,167,322 | SH | SOLE | n/a | 3,167,322 | 0 | 0 | |
BOK Financial | Common | 05561Q201 | 348,371 | 5,826,570 | SH | SOLE | n/a | 5,826,570 | 0 | 0 | |
Cognizant Technology Solutions | Common | 192446102 | 4,502 | 75,000 | SH | SOLE | n/a | 75,000 | 0 | 0 | |
Calpine Corporation | Common | 131347304 | 2,435 | 168,292 | SH | OTR | n/a | 0 | 0 | 168,292 | |
Cimpress | Common | N20146101 | 1,345 | 16,573 | SH | OTR | n/a | 0 | 0 | 16,573 | |
Express Scripts | Common | 30219G108 | 1,026 | 11,741 | SH | OTR | n/a | 0 | 0 | 11,741 | |
JPMorgan Chase & Co | Common | 46625H100 | 2,729 | 41,334 | SH | OTR | n/a | 0 | 0 | 41,334 | |
Liberty Broadband Corp | Common | 530307305 | 3,445 | 66,421 | SH | OTR | n/a | 0 | 0 | 66,421 | |
Liberty Global - Series C | Common | G5480U120 | 1,821 | 44,674 | SH | OTR | n/a | 0 | 0 | 44,674 | |
Liberty Global - USD0.01A | Common | G5480U104 | 650 | 15,337 | SH | OTR | n/a | 0 | 0 | 15,337 | |
Liberty Lilac Group - Series C | Common | G5480U153 | 224 | 5,204 | SH | OTR | n/a | 0 | 0 | 5,204 | |
Live Nation Entertainment Inc. | Common | 538034109 | 547 | 22,271 | SH | OTR | n/a | 0 | 0 | 22,271 | |
Mastercard CL A | Common | 57636Q104 | 869 | 8,921 | SH | OTR | n/a | 0 | 0 | 8,921 | |
Microsoft Corp | Common | 594918104 | 4,234 | 76,315 | SH | OTR | n/a | 0 | 0 | 76,315 | |
Sirius XM Holdings Inc. | Common | 82968B103 | 1,174 | 288,444 | SH | OTR | n/a | 0 | 0 | 288,444 | |
Valeant Pharmaceuticals | Common | 91911K102 | 2,987 | 29,382 | SH | OTR | n/a | 0 | 0 | 29,382 |